Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 2

Значение и возможности сочетания лекарственной терапии хронической обструктивной болезни легких и методов легочной реабилитации (клинические примеры)
А.С. Белевский, Н.Н. Мещерякова

References
1. Leshchenko IV, Ovcharenko SI. Chronic obstructive pulmonary disease. In: Respiratory medicine: 3 volume guide. Chuchalin AG, editor. 2nd ed., revised. V. I . Moscow: Litterra; 2017: 507-43 (In Russian).
2. Weisman IM, Zeballos RJ. An integrative approach to the interpretation of cardiopulmonary exercise testing. In: Clinical exercise testing. Progress in Respiratory Research. V. 32. Weisman IM, Zebellos RJ, editors. Basel, Switzerland: Karger; 2002: 300-22.
3. Grippi MA. Pulmonary pathophysiology. Moscow: Binom; 2008. 304 p. (In Russian).
4. Puente-Maestu L, Sánz ML, Sánz P, Ruíz de Oña JM, Rodríguez-Hermosa JL, Whipp BJ. Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. The European Respiratory Journal 2000 Jun;15(6):1026-32.
5. Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. European Respiratory Review 2009 Jun;18(112):66-79.
6. Decremer M, Demedts M, Rochette F, Billiet L. Maximal transrespiratory pressures in obstructive lung disease. Bulletin Européen de Physiopathologie Respiratoire 1980 Jul;16(4):479-90.
7. Rochester DF, Braun NM. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. The American Review of Respiratory Disease 1985 Jul;132(1):42-7.
8. Perez T, Becquart LA, Stach B, Wallaert B, Tonner AB. Inspiratory muscle strength and endurance in steroid-dependent asthma. American Journal of Respiratory and Critical Care Medicine 1996 Feb;153(2):610-5.
9. Bégin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. The American Review of Respiratory Disease 1991 May;141(5 Pt 1):905-12.
10. Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clinics in Chest Medicine 1988 Jun;9(2):237-48.
11. Hamiltin AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. American Journal of Respiratory and Critical Care Medicine 1995 Dec;152(6 Pt 1):2021-31.
12. Agusti A. Systemic effects of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2005;2(4):367-70.
13. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. American Journal of Respiratory and Critical Care Medicine 1996 Mar;153(3):976-80.
14. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. The American Review of Respiratory Disease1992 Oct;142(4):935-40.
15. Jeffery Mador M, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2000 Feb;161(2 Pt 1):447-53.
16. Seay D, Debigare R, LeBlanc P, Mador MJ, Cote CH, Jobin J, Maltais F. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2003 Aug;168(4):425-30.
17. Pedersen BK, Fischer CP. Beneficial health effects of exercise – the role of IL-6 as a myokine. Trends in Pharmacological Sciences 2007 Apr;28(4):152-6.
18. Casadevall C, Coronell C, Ramirez-Sarmiento AL, Barreiro E, Orozco-Levi M, Gea J. Effects of a bout of exhaustive ventilatory effort in the intercostal muscles of severe COPD: expression profiles of local inflammatory and regeneration markers. Available from: https://www.ers-education.org/events/ers-live.aspx?idParent=4616 Accessed 2018 Oct 03.
19. Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Effect of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 2004 Jun;125(6):2021-8.
20. Spruit MA, Gosselink R, Troosters T, De Paepe K, Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. The European Respiratory Journal 2002 Jun;19(6):1072-8.
21. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilator requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005 Oct;128(4):2025-34.
22. Gale NS, Duckers JM, Enright S, Cockcroft JR, Shale DJ, Bolton CE. Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulmonary Medicine 2011 Apr;11:20.
23. Camillo CA, Laburu Vde M, Gonçalves NS, Cavalheri V, Tomasi FP, Hernandes NA, Ramos D, Marquez Vanderlei LC, Cipulo Ramos EM, Probst VS, Pitta F. Improvement of heart rate variability after exercise training and its predictors in COPD. Respiratory Medicine 2011 Jul;105(7):1054-62.
24 Pogontseva E. Expert: Rostov region healthcare will miss 3,74 billion rubles due to monetization of benefits in 2018. Available from: https://pharmvestnik.ru/publs/lenta/v-rossii/ekspert-zdravooxranenie-rostovskoj-9-8-18.html#.W3TjM84zbIU Accessed 2018 Oct 04 (In Russian).
25. Kalinovskaya E. RPF: the Government did not tell the President all truth about drug supply. Available from: https://pharmvestnik.ru/publs/lenta/v-rossii/onf-praviteljstvo-ne-vse-rasskazalo.html#.W3TjkM4zbIU Accessed 2018 Oct 04 (In Russian).
26. Pogontseva E. Physicians’ pay rise in Ulyanovsk at the expense of savings on drugs. Available from: https://pharmvestnik.ru/publs/lenta/v-rossii/v-uljjanovske-zarplaty-vracham-3-7-18.html#.W3TkN84zbIU Accessed 2018 Oct 04 (In Russian).
27. Pogontseva E. Bashkortostan: problem solution of preferential drug provision is postponed again. Available from: https://pharmvestnik.ru/publs/lenta/v-rossii/bashkortostan-reshenie-6-6-18.html#.W3Tks84zbIU Accessed 2018 Oct 04 (In Russian).
28. Symbicort® Turbuhaler®. Instruction for medical use. Available from: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=7398258f-1c10-403f-a87d-a1b9a8fb7614&t= Accessed 2018 Oct 03 (In Russian).
29. Spiriva®. Instructions for medical use. Available from: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=2698d38c-0b03-45f7-8049-1d6c60f6a214&t= Accessed 2018 Oct 03 (In Russian).
30. Formisonide®-nativ. Instructions for medical use. Available from: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=7948e4fc-26cf-46d4-a032-58b5f31d5b52&t= Accessed 2018 Oct 03 (In Russian).
31. Tiotropium-Nativ. Instructions for medical use. Available from: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e16355f1-a7c6-4f7e-a437-dac79d1c9e2f&t= Accessed 2018 Oct 03 (In Russian).
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]